CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

In recent years the information about relevance of cardiopulmonary exercise testing (CPET) in complex assessment of pulmonary arterial hypertension (PAH) patients and chronic thromboembolic pulmonary hypertension (CTEPH) patients have been accumulating. Parameters of CPET, such as peak oxygen consumption (Vo2 peak) and ventilation equivalents (VE/Vco2) are very important in risk stratification in patients with PAH, also as distance in 6-minute walking test, the echocardiography and right heart catheterization results, N-terminal prohormone of natriuretic peptide according to the European Society of Cardiology and European Respiratory Society guidelines on diagnosis and treatment of pulmonary hypertension. However, there are no parameters, which can be used in clinical practice to reflect the risk of mortality during 1 year in patients with CTEPH. The aim of our study was to assess the role of CPET in risk stratification, achieving therapy goals and making decision about therapy escalation in patients with PAH and CTEPH. Results of our pilot study demonstrated, that CPET parameters are the reliable markers to reflect the PAH and CTEPH progression. The CPET is necessary for pathogenic therapy efficacy assessment and for making decision of therapy escalation in patients with PAH, also as in CTEPH patients. The critical role of CPET in risk stratification in PAH and CTEPH patients should be emphasized.

cardiopulmonary exercise test, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, risk stratification

1. Lai Y-C., Potoka K.C., Champion H.C., Mora A.L., Gladwin M.T. Pulmonary arterial hypertension: the clinical syndrome. Circ Res 2014;115:115-130.

2. Piazza G., Goldhaber S.Z. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011;364:351-360.

3. Pinkstaff S.O., Burger C.D., Daugherty J. et al. Cardiopulmonary exercise testing in patients with pulmonary hypertension: clinical recommendations based on a review of the evidence. Expert Rev Respir Med 2016;10:279-295.

4. Taran I.N., Valieva Z.S., Marytnyuk Т.V. et al. The value of cardiopulmonary exercise testing in the diagnostic algorithm of examination in patients with pulmonary arterial hypertension. Medical alphabet 2016, 30(3): 19-24[in Russian].

5. Arena R., Lavie C.J., Milani R.V. et al. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant 2010;29:159-173.

6. Galie` N., Humbert M., Vachiery J-L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37: 67-124.

7. Chazova I.Ye., Martynyuk T.V., Nakonechnikov S.N. Results of the European Congress of Cardiology 2015: a new version of the guidelines on diagnosis and treatment of pulmonary hypertension. Eurasian Heart Journal 2015; 4:3-10 [in Russian].

8. Sun X.G., Hansen J.E., Oudiz R.J., Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104 : 429-435.

9. D’Alonzo G.E., Gianotti L.A., Pohil RL, Reagle RR et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest 1987;92:57-62.

10. Riley M.S., Po ́rsza ́sz J., Engelen M.P.,Brundage B.H.,Wasserman K. Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans. Eur J ApplPhysiol 2000;83:63-70.

11. Laveneziana P., Garcia G., Joureau B. et al. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. EurRespir J 2013;41:578-587.

12. Laveneziana P., Montani D., Dorfmu ̈ller P. et al. Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations. EurRespir J 2014; 44 :1069-1072.

13. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J RespirCrit Care Med 2003;167 : 211-277.

14. Godinas L.et al. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant.May 2017,S1053-2498(17)31805-3.

15. Naeije R.,Vanderpool R.,Dhakal B.P. et al. Exerciseinduced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 2013;187:576-583.

16. Janicki J.S., Weber K.T., Likoff M.J., Fishman A.P. The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 1985; 72:1270-1278.

17. Groepenhoff H., Westerhof N., Jacobs W. et al. Exercise stroke volume and heart rate response differ in right and left heart failure. Eur J Heart Fail 2010; 12:716-720.

18. Chemla D., Castelain V., Hoette S. et al. Strong linear relationship between heart rate and mean pulmonary artery pressure in exercising patients with severe precapillary pulmonary hypertension. Am J Physiol Heart CircPhysiol 2013;305 : 769-777.

19. Nootens M., Wolfkiel C.J., Chomka E.V., Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 1995;75: 374-377.

20. Holverda S., Gan CT-J., Marcus J.T. et al. Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol 2006;47:1732-1733.

21. Kasner M., Westermann D., Steendijk P. et al. Left ventricular dysfunction induced by non severe idiopathic pulmonary arterial hypertension: a pressure-volume relationship study. Am J RespirCrit Care Med 2012;186 : 181-189.

22. Whipp B.J., Ward S.A. Determinants and control of breathing during muscular exercise. Br J Sports Med 1998;32:199-211.

23. Weatherald et al.: Exercise Responses in Pulmonary Hypertension. Annals ATS July 2017, Volume 14:84-92.

24. McCabe C., Deboeck G., Harvey I. et al. Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism. Thromb Res 2013;132 : 659-665.

25. Scheidl S.J., Englisch C., Kovacs G. et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. EurRespir J 2012;39:119-124.